Ledger.Open graph →
SEC Form D · filed October 10, 2014

Mati Therapeutics Inc

Offering
$13.8M
Sold
$150K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
AUSTIN, TX
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (11)

Robert L. Butchofsky Ii · Austin, TXExec · DirectorDeepank L. Utkede · Austin, TXExec · DirectorChris L. Muller · Austin, TXExec · DirectorCameron L. Nelson · Austin, TXExecJon L. Stein · Chicago, ILExec · DirectorThomas W. Halloran · Braintree, MAExec · DirectorNordic Venture Partners, LLC · Sioux Falls, SDExec · DirectorTC Group, L.L.C · Washington, Washington, D.C.Exec · DirectorYonatan C. Cheifetz · Palo Alto, CAExec · DirectorLaurel C. Bowden · Palo Alto, CAExec · DirectorYacov E. Lifshitz · Palo Alto, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Mati Therapeutics Inc. — SEC Form D filing (2014) | Ledger